Cargando…

Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study

Comparative pharmacodynamic (PD) analyses on different dosing schedules for cholecalciferol supplementation are limited. This was an open-label, randomized, parallel-group study involving 75 healthy individuals deficient in vitamin D (baseline 25OHD < 20 ng/mL) receiving oral cholecalciferol with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fassio, Angelo, Gatti, Davide, Rossini, Maurizio, Benini, Camilla, Fracassi, Elena, Bertoldo, Eugenia, Viapiana, Ombretta, Milleri, Stefano, Gatti, Matteo, Adami, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308331/ https://www.ncbi.nlm.nih.gov/pubmed/34371803 http://dx.doi.org/10.3390/nu13072293

Ejemplares similares

Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study
por: Fassio, Angelo, et al.
Publicado: (2020)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study
por: Adami, Giovanni, et al.
Publicado: (2022)

Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides
por: Adami, Giovanni, et al.
Publicado: (2021)

Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs)
por: Adami, Giovanni, et al.
Publicado: (2023)

The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders
por: Bertoldo, Eugenia, et al.
Publicado: (2021)

Machine learning to characterize bone biomarkers profile in rheumatoid arthritis
por: Adami, Giovanni, et al.
Publicado: (2023)

Changes in bone turnover markers and bone modulators during abatacept treatment
por: Adami, Giovanni, et al.
Publicado: (2023)

Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data
por: Fassio, Angelo, et al.
Publicado: (2022)

Acute Phase Reaction and Fracture Risk Reduction: Are Gamma‐Delta T Cells and Hypovitaminosis D the Missing Link?
por: Adami, Giovanni, et al.
Publicado: (2022)

Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment
por: Rotta, Denise, et al.
Publicado: (2020)

Osteoporosis in 10 years time: a glimpse into the future of osteoporosis
por: Adami, Giovanni, et al.
Publicado: (2022)

Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment
por: Fassio, Angelo, et al.
Publicado: (2020)

Anti-CCP antibodies and bone
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture
por: Rossini, Maurizio, et al.
Publicado: (2013)

Radiofrequency echographic multi-spectrometry and DXA for the evaluation of bone mineral density in a peritoneal dialysis setting
por: Fassio, Angelo, et al.
Publicado: (2022)

Osteoporosis in Rheumatic Diseases
por: Adami, Giovanni, et al.
Publicado: (2019)

Gender disparity in authorship of guidelines and recommendations in rheumatology
por: Adami, Giovanni, et al.
Publicado: (2020)

Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Orsolini, Giovanni, et al.
Publicado: (2018)

Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
por: Giovanni, Orsolini, et al.
Publicado: (2018)

Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study
por: Adami, G., et al.
Publicado: (2021)

Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013)

Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides?
por: Adami, Giovanni, et al.
Publicado: (2021)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
por: Cioffi, Giovanni, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
por: Cioffi, Giovanni, et al.
Publicado: (2020)

Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis
por: Bixio, Riccardo, et al.
Publicado: (2022)

Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes
por: Chiodini, Iacopo, et al.
Publicado: (2021)

The Use of Oral Amino‐Bisphosphonates and Coronavirus Disease 2019 (COVID‐19) Outcomes
por: Degli Esposti, Luca, et al.
Publicado: (2021)

Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency
por: Sosa Henríquez, Manuel, et al.
Publicado: (2020)

Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS)
por: Bertoldo, Francesco, et al.
Publicado: (2022)

Reply to Wimalawansa, S.J. Comment on “Bertoldo et al. Definition, Assessment, and Management of Vitamin D Inadequacy: Suggestions, Recommendations, and Warnings from the Italian Society for Osteoporosis, Mineral Metabolism and Bone Diseases (SIOMMMS). Nutrients 2022, 14, 4148”
por: Bertoldo, Francesco, et al.
Publicado: (2023)

Vitamin D and Osteogenesis Imperfecta in Pediatrics
por: Coccia, Francesco, et al.
Publicado: (2023)

Raising awareness on the therapeutic role of cholecalciferol in CKD: a multidisciplinary-based opinion
por: Giannini, Sandro, et al.
Publicado: (2017)

The Association between Weight Gain/Restoration and Bone Mineral Density in Adolescents with Anorexia Nervosa: A Systematic Review
por: El Ghoch, Marwan, et al.
Publicado: (2016)

Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series
por: Cianferotti, Luisella, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4mm335sbnjb4ot06m726qha6e2